Vertex (VRTX) Form 144: Affiliate Plans Share Sales

Vertex Pharmaceuticals filed a Form 144 notice reporting proposed sales of Common Stock by an affiliate and disclosed recent restricted stock vesting events.

Rhea-AI Filing Summary

Vertex Pharmaceuticals filed a Form 144 notice reporting proposed sales of Common Stock by an affiliate and disclosed recent restricted stock vesting events. The filing lists vesting issuances to Fidelity Brokerage Services LLC on 02/13/2026, 02/17/2026, 02/24/2026, and 03/01/2026, and multiple proposed sales by Jonathan P. Biller on February 11–25, 2026.

Key Figures

Proposed sale (02/11/2026): 1,925 shares Proposed sale (02/13/2026): 988 shares Proposed sale (02/17/2026): 2,476 shares +5 more

8 metrics

Proposed sale (02/11/2026) 1,925 shares Jonathan P. Biller proposed sale on 02/11/2026

Proposed sale (02/13/2026) 988 shares Jonathan P. Biller proposed sale on 02/13/2026

Proposed sale (02/17/2026) 2,476 shares Jonathan P. Biller proposed sale on 02/17/2026

Proposed sale (02/18/2026) 1,244 shares Jonathan P. Biller proposed sale on 02/18/2026

Proposed sale (02/25/2026) 945 shares Jonathan P. Biller proposed sale on 02/25/2026

Vesting issuance (02/13/2026) 825 shares Restricted Stock Vesting to Fidelity Brokerage Services LLC on 02/13/2026

Vesting issuance (02/17/2026) 414 shares Restricted Stock Vesting to Fidelity Brokerage Services LLC on 02/17/2026

Vesting issuance (03/01/2026) 3,640 shares Restricted Stock Vesting to Fidelity Brokerage Services LLC on 03/01/2026

Key Terms

Form 144, Restricted Stock Vesting, Issuer, Selling Stockholder

4 terms

Form 144 regulatory

"Form 144 notice reporting proposed sales of Common Stock by an affiliate"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Restricted Stock Vesting entries dated 02/13/2026, 02/17/2026, 02/24/2026, 03/01/2026"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Issuer regulatory

"Entries labeled 'Issuer' associated with restricted stock vesting and compensation"

Selling Stockholder financial

"Rows listing Jonathan P. Biller with dates, share counts, and dollar amounts"

A selling stockholder is an individual or entity that owns shares of a company's stock and chooses to sell some or all of those shares to others. This often occurs when the owner wants to cash in on their investment or reduce their stake. For investors, understanding who the selling stockholder is can provide insights into potential changes in the company's ownership or market activity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Vertex's (VRTX) Form 144 disclose?

The Form 144 discloses proposed sales of Common Stock by an affiliate and lists recent restricted stock vesting events. It names Fidelity Brokerage Services LLC for vesting and shows multiple proposed sales by Jonathan P. Biller with dates and share counts.

How many shares did Jonathan P. Biller propose to sell in February 2026?

The filing lists multiple proposed sales by Jonathan P. Biller: 1,925 shares on 02/11/2026, 988 shares on 02/13/2026, 2,476 shares on 02/17/2026, 1,244 shares on 02/18/2026, and 945 shares on 02/25/2026. Dollar amounts are shown alongside each sale.

Which vesting issuances are listed in the filing for VRTX?

The filing lists restricted stock vesting issuances to Fidelity Brokerage Services LLC on 02/13/2026 (825 shares), 02/17/2026 (414 shares), 02/24/2026 (314 shares), and 03/01/2026 (3,640 shares) labeled as compensation-related vesting.

Does the Form 144 show who receives sale proceeds?

The excerpt lists proposed sellers and share counts with corresponding dollar figures for each sale by Jonathan P. Biller. It does not state how proceeds will be used or who will receive them beyond the named selling party in each row.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/06/2026 - 02:13 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001744749
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERTEX PHARMACEUTICALS INC / MA
SEC File Number	000-19319
Address of Issuer	50 NORTHERN AVENUE BOSTON MASSACHUSETTS 02210
Phone	6173416393
Name of Person for Whose Account the Securities are To Be Sold	Biller Jonathan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5193	2203149.23	253805417	05/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2026	Restricted Stock Vesting	Issuer			825	02/13/2026	Compensation
Common	02/17/2026	Restricted Stock Vesting	Issuer			414	02/17/2026	Compensation
Common	02/24/2026	Restricted Stock Vesting	Issuer			314	02/24/2026	Compensation
Common	03/01/2026	Restricted Stock Vesting	Issuer			3640	03/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jonathan P. Biller 50 Northern Avenue Boston MA 02210	Common	02/11/2026	1925	886327.75
Jonathan P. Biller 50 Northern Avenue Boston MA 02210	Common	02/13/2026	988	493012.00
Jonathan P. Biller 50 Northern Avenue Boston MA 02210	Common	02/17/2026	2476	1211902.96
Jonathan P. Biller 50 Northern Avenue Boston MA 02210	Common	02/18/2026	1244	589257.92
Jonathan P. Biller 50 Northern Avenue Boston MA 02210	Common	02/25/2026	945	459600.75

144: Remarks and Signature

Remarks
Date of Notice	05/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Jonathan Biller
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)